Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | SCN1A | P35498 | 1/20 | 0.31 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.31 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2577639 | 1.00 | GAA (0.33) | GAAADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL28721500 | 0.88 | ACHE (0.35) | — | |
| SCHEMBL2585364 | 0.87 | GAA (0.35) | GAAADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL2575144 | 0.87 | GAA (0.35) | GAAADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL2581450 | 0.85 | GAA (0.33) | GAAADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL2577690 | 0.81 | GAA (0.40) | GAA | |
| SCHEMBL301451 | 0.78 | HRH3 (0.34) | GAA | |
| SCHEMBL2582384 | 0.78 | GAA (0.35) | GAAADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL2577710 | 0.77 | ACHE (0.36) | GAA | |
| SCHEMBL2584255 | 0.77 | GAA (0.38) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8049027-B2 | Organosilicon compound having amino group and its production method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2180001-A1 | Organosilicon compound having amino group and its production method | Shin-Etsu Chemical Co., Ltd. (JP) | 2010-04-28 | — | — | EP | disclosed |
| US-20100099866-A1 | ORGANOSILICON COMPOUND HAVING AMINO GROUP AND ITS PRODUCTION METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099866-A1 | ORGANOSILICON COMPOUND HAVING AMINO GROUP AND ITS PRODUCTION METHOD | HRH3, H1-0, H1-2 | GAA 4182/4885ADRA2A 2334/4885ADRA2B 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.